The Vaccine Investment Strategy (VIS) is Gavi’s evidence-driven process for identifying new and under-used vaccines of the highest importance to Gavi-supported countries and with the greatest need for financial support. The VIS allows Gavi to take stock of the vaccine landscape to assess the cost, impact, value, and programmatic feasibility of relevant products. It informs the Board of the various options for future investments, compares those options with each other and with existing investments, including trade-offs and opportunities for synergy. The VIS also provides partners, manufacturers, and Gavi-supported countries with key information to support planning over a longer time horizon.
Gavi is beginning the development of VIS 2024. Following an 18-month evidence-driven prioritisation process, the Gavi Board will make final investment decisions in June 2024. VIS 2024 will include new vaccines and passive immunisation products anticipated to be available by 2030, as well as potential incremental investments for the existing Gavi portfolio and recommendations on vaccine prioritization, particularly in a post-pandemic context.
Gavi is seeking expressions of interest from independent subject matter experts to join a VIS Steering Committee to provide technical and strategic guidance and oversight throughout this process. Country-level experience will be particularly valued.
The VIS Steering Committee will be convened to provide expert advice across multiple perspectives and deliberations and will provide technical input into the development of Gavi Secretariat’s recommendations to the Programme and Policy Committee (PPC) and Gavi Board. The Steering Committee will:
We are currently looking for up to 8 independent experts to join the VIS Steering Committee, with diverse and global expertise in the following areas:
The deadline for submissions of applications is Wednesday 3 October 2022. Applications including a CV and short expression of interest should be sent to email@example.com. Please share this announcement with your networks.